Cedar Hill Associates »

SPDR S&P Biotech shares owned by Cedar Hill Associates

Quarter-by-quarter ownership of SPDR S&P Biotech (XBI) shares owned by Cedar Hill Associates from 13F filings

Historical chart of Cedar Hill Associates investment in SPDR S&P Biotech

Tip: Access up to 7 years of quarterly data

All positions including SPDR S&P Biotech held by Cedar Hill Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in SPDR S&P Biotech by Cedar Hill Associates

Quarter filed Position value Share count Share price at filing
2018-12-31 $419k 5.8k 71.69

More positions owned by Cedar Hill Associates

Vaneck Vec Invt Grade Fltg Rate Etf etf/closed end fund (FLTR)
iShares S&P 500 Index (IVV)
Ishares Core Msci Eafe Etf core msci eafe (IEFA)
Vanguard Short-Term Bond ETF (BSV)
iShares S&P MidCap 400 Index (IJH)
iShares Barclays 1-3 Year Cred Bd Fd ETF (IGSB)
Tortoise Energy Infrastructure
iShares S&P SmallCap 600 Index (IJR)
Nuveen Barclays Shrt Term Muni bdfund (SHM)
Vanguard Emerging Markets ETF (VWO)
Brookfield Asset Management
Apple (AAPL)
Ishares Tr core msci intl (IDEV)
IAC/InterActive
Thermo Fisher Scientific (TMO)

View all positions for Cedar Hill Associates

Top funds holding SPDR S&P Biotech

Goldman Sachs Group
Citadel Advisors
Millennium Management
UBS Group
Bank of America Corporation
Citigroup
venBio Select Advisor
Jpmorgan Chase & Co
Bnp Paribas Arbitrage, Snc
Nantahala Capital Management
Healthcare Of Ontario Pension Plan Trust Fund
Moore Capital Management
Barclays
Perceptive Advisors
Gts Securities

View all funds holding SPDR S&P Biotech